Department of Cardiac, Thoracic, Vascular, and Public Health Sciences, University of Padua, Padova.
Cardiological Unit, Monzino Hospital, University of Milan, Milan, Italy.
J Cardiovasc Med (Hagerstown). 2022 Mar 1;23(3):167-175. doi: 10.2459/JCM.0000000000001233.
Heart transplantation represents the gold standard for end-stage heart failure. However, due to the increasing demand and the shortage of available organs, donor supply remains the main limitation. Marginal donor hearts in high-risk candidates who do not meet standard listing criteria are the only alternative when life expectancy is limited, but their use is still debated. Surgical correction of detected coronary lesions or valvular heart defects allows further enlargement of the number of available organs. In this article, we offer a literature review on this topic and report two marginal donor hearts with angiography evidence of coronary stenosis and preserved ventricular function, which underwent concomitant myocardial revascularization during heart implantation.
心脏移植是终末期心力衰竭的金标准。然而，由于需求不断增加和可供器官短缺，供体供应仍然是主要限制因素。在预期寿命有限的情况下，对于不符合标准列入标准的高危候选者，边缘供体心脏是唯一的选择，但它们的使用仍存在争议。对检测到的冠状动脉病变或心脏瓣膜缺陷进行手术矫正可进一步扩大可供器官的数量。本文就这一主题进行了文献回顾，并报告了两例边缘供体心脏，其冠状动脉狭窄的血管造影证据和保留的心室功能，在心脏移植过程中同时进行了心肌血运重建。
